Hyperphosphorylated tau in young and middle-aged subjects
Open Access
- 11 December 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 123 (1), 97-104
- https://doi.org/10.1007/s00401-011-0906-z
Abstract
The brain tissue obtained from ninety-five cognitively unimpaired subjects, with ages ranging from 22 to 50 years upon death, were immunohistochemically assessed for neurodegenerative changes, i.e., hyperphosphorylated tau (HPτ) and β-amyloid (Aβ) pathology in predilection neuroanatomical areas. HPτ pathology was observed in the transentorhinal cortex and/or the locus coeruleus (LC) in 33% of the subjects, without any obvious risk factors known to alter the microtubule-associated protein. HPτ pathology was noted in the LC in 25 out of 83 subjects (30%), lacking concomitant cortical Aβ or transentorhinal HPτ pathology. This observation was present even when assessing only one routine section of 7 μm thickness. The recent suggestion of prion-like propagation of neurodegeneration and the finding of neurodegeneration being quite common in middle-aged persons is alarming. It is noteworthy, however, that a substantial number of neurologically unimpaired subjects even at a very old age display only sparse to modest extent of neurodegenerative pathology. Thus, only a subset of subjects with neurodegenerative changes early in life seem to progress to a symptomatic disease with ageing. This observation brings forth the notion that other, yet unknown modifying factors influence the progression of degeneration that leads to a symptomatic disorder. The known association between alterations in the LC and mood disorders, and the finding of the LC being frequently affected with HPτ pathology suggest that clinicopathological studies on young subjects both with or without mood disorders are warranted.Keywords
This publication has 35 references indexed in Scilit:
- Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective studyThe Lancet Neurology, 2011
- Identification of Low Molecular Weight Pyroglutamate Aβ Oligomers in Alzheimer DiseaseOnline Journal of Public Health Informatics, 2010
- Does Alzheimer's disease begin in the brainstem?Neuropathology and Applied Neurobiology, 2009
- Transmission and spreading of tauopathy in transgenic mouse brainNature, 2009
- Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe ConsortiumBrain Pathology, 2008
- History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer diseaseNeurology, 2008
- Effects of Cell Cycle Inhibitors on Tau Phosphorylation in N2aTau3R CellsJournal of Molecular Neuroscience, 2008
- β-Amyloid Aggregation in Human Brains With Cerebrovascular LesionsStroke, 2006
- 15-year longitudinal study of blood pressure and dementiaThe Lancet, 1996
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991